CH Health Tech Advisory

Insights

Notes on scaling AI in healthcare and TechBio.

Field notes by Christian Hein on how AI moves from announcements and pilots into workflows, operating models, and investment decisions in regulated healthcare.

Selected essays

  1. 01Isomorphic Labs at $50 Billion: A Bet on Human Data That Mostly Does Not Exist YetIsomorphic Labs raised $5 billion at a reported valuation of about $50 billion, with no drug in the clinic yet. I think that price holds only if Isomorphic solves the data problem in human biology.2 min read
  2. 02I said Anthropic would carry no drug asset. I was wrongIn IPO week, Anthropic disclosed a drug program it bought from Mithril Medicine, a one-person startup. Here is what that changes in my August prediction, and what still holds for pharma.2 min read
  3. 03Vertex's chairman calls AI cure timelines "complete BS"Vertex's executive chairman called "complete BS" the claims that AI will cure most diseases within seven years. Ten years from now, I expect most human diseases will still be uncured.1 min read

187 posts